Literature DB >> 2141748

Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus.

I Ferrer1, F Gullotta.   

Abstract

Samples of the hippocampus of four patients with Down's syndrome [two men aged 35 and 36 years with no evidence of Alzheimer's disease (AD) and two patients aged 47 and 55 years with associated AD] were obtained at post mortem and processed according to the rapid Golgi method. A significant reduction in the number of dendritic spines (DS) was found in the apical (middle, distal and oblique segments) and basilar (thick and thin segments) dendritic arbors of CA1 and CA2-3 pyramidal neurons in patients with Down's syndrome and no AD when compared to age-matched controls. An additional decrease of DS in every segment occurred in Down's patients with associated AD when compared to age-matched controls and Down's patients with no AD. In Down's syndrome (either associated or not to AD) thin basilar dendrites were the most severely involved; in AD patients CA1 pyramids were more severely affected than pyramidal neurons of the CA2-3 subfield.

Entities:  

Mesh:

Year:  1990        PMID: 2141748     DOI: 10.1007/bf00294247

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

1.  Alzheimer's disease and Down's syndrome.

Authors:  D L Price; P J Whitehouse; R G Struble; J T Coyle; A W Clark; M R Delong; L C Cork; J C Hedreen
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

2.  Quantitative evidence for selective dendritic growth in normal human aging but not in senile dementia.

Authors:  S J Buell; P D Coleman
Journal:  Brain Res       Date:  1981-06-09       Impact factor: 3.252

3.  Decreased numbers of dendritic spines on cortical pyramidal neurons in dementia. A quantitative Golgi study on biopsy samples.

Authors:  I Catalá; I Ferrer; E Galofré; I Fábregues
Journal:  Hum Neurobiol       Date:  1988

4.  Quantitative study on dendrites and dendritic spines in Alzheimer's disease and senile dementia.

Authors:  P Mehraein; M Yamada; E Tarnowska-Dziduszko
Journal:  Adv Neurol       Date:  1975

5.  Spine distribution along the apical dendrites of the pyramidal neurons in Down's syndrome. A quantitative Golgi study.

Authors:  M Suetsugu; P Mehraein
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

6.  Dendritic extent in human dentate gyrus granule cells in normal aging and senile dementia.

Authors:  D G Flood; S J Buell; G J Horwitz; P D Coleman
Journal:  Brain Res       Date:  1987-02-03       Impact factor: 3.252

7.  A direct demonstration of the perforant pathway terminal zone in Alzheimer's disease using the monoclonal antibody Alz-50.

Authors:  B T Hyman; L J Kromer; G W Van Hoesen
Journal:  Brain Res       Date:  1988-05-31       Impact factor: 3.252

Review 8.  The neurobiologic consequences of Down syndrome.

Authors:  J T Coyle; M L Oster-Granite; J D Gearhart
Journal:  Brain Res Bull       Date:  1986-06       Impact factor: 4.077

9.  The topography of plaques and tangles in Down's syndrome patients of different ages.

Authors:  D M Mann; P O Yates; B Marcyniuk; C R Ravindra
Journal:  Neuropathol Appl Neurobiol       Date:  1986 Sep-Oct       Impact factor: 8.090

10.  Abnormal neuronal development in the visual cortex of the human fetus and infant with down's syndrome. A quantitative and qualitative Golgi study.

Authors:  S Takashima; L E Becker; D L Armstrong; F Chan
Journal:  Brain Res       Date:  1981-11-23       Impact factor: 3.252

View more
  62 in total

1.  Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume.

Authors:  Owen Carmichael; Jing Xie; Evan Fletcher; Baljeet Singh; Charles DeCarli
Journal:  Neurobiol Aging       Date:  2011-12-14       Impact factor: 4.673

Review 2.  Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease.

Authors:  Peter Penzes; Jon-Eric Vanleeuwen
Journal:  Brain Res Rev       Date:  2011-01-26

Review 3.  Casting a net on dendritic spines: the extracellular matrix and its receptors.

Authors:  Lorraine E Dansie; Iryna M Ethell
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

4.  Enhanced dendritic spine number of neurons of the prefrontal cortex, hippocampus, and nucleus accumbens in old rats after chronic donepezil administration.

Authors:  Faviola Alcantara-Gonzalez; Ismael Juarez; Oscar Solis; Isaura Martinez-Tellez; Israel Camacho-Abrego; Eliezer Masliah; Raul Mena; Gonzalo Flores
Journal:  Synapse       Date:  2010-10       Impact factor: 2.562

5.  Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.

Authors:  W S Griffin; J G Sheng; J E McKenzie; M C Royston; S M Gentleman; R A Brumback; L C Cork; M R Del Bigio; G W Roberts; R E Mrak
Journal:  Neurobiol Aging       Date:  1998 Sep-Oct       Impact factor: 4.673

6.  Epigenetic regulation of neuronal dendrite and dendritic spine development.

Authors:  Richard D Smrt; Xinyu Zhao
Journal:  Front Biol (Beijing)       Date:  2010-08

7.  Increasing CREB function in the CA1 region of dorsal hippocampus rescues the spatial memory deficits in a mouse model of Alzheimer's disease.

Authors:  Adelaide P Yiu; Asim J Rashid; Sheena A Josselyn
Journal:  Neuropsychopharmacology       Date:  2011-07-06       Impact factor: 7.853

8.  Down syndrome's brain dynamics: analysis of fractality in resting state.

Authors:  Sahel Hemmati; Mehran Ahmadlou; Masoud Gharib; Roshanak Vameghi; Firoozeh Sajedi
Journal:  Cogn Neurodyn       Date:  2013-03-27       Impact factor: 5.082

9.  Environmental enrichment reveals effects of genotype on hippocampal spine morphologies in the mouse model of Fragile X Syndrome.

Authors:  Julie C Lauterborn; Matiar Jafari; Alex H Babayan; Christine M Gall
Journal:  Cereb Cortex       Date:  2013-09-17       Impact factor: 5.357

10.  Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.

Authors:  Chelsee A Hewitt; King-Hwa Ling; Tobias D Merson; Ken M Simpson; Matthew E Ritchie; Sarah L King; Melanie A Pritchard; Gordon K Smyth; Tim Thomas; Hamish S Scott; Anne K Voss
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.